Search Results

May 07, 2026, 11:10 ET /C O R R E C T I O N -- Kensington Investment Company, Inc./

More news about: Kensington Investment Company, Inc.

May 07, 2026, 11:09 ET Digital Therapeutics Market to Reach US$ 38.2 Billion by 2030 as Software-Based Care Redefines Modern Medicine - Wissen Research

identify new growth opportunities across global marketsCompany Contact:Wissen Research LLC,Gould St, Ste R,Sheridan, WY 82801,Phone: (+1) 510 240 9853Email: [email protected]

More news about: Wissen Research LLC

May 07, 2026, 11:08 ET Hyundai and Hyundai Hope on Wheels Honored with Multiple 2026 Merit Awards for Marketing and Communications

headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is 

More news about: Hyundai Motor America

May 07, 2026, 11:00 ET West Monroe Earns Top Stevie® Honor for AI-Driven Culture of Innovation in 2026; Bret Greenstein Named an AI Leader of the Year

Community, a one-of-its-kind grassroots network where builders can get extra guidance and resources and connect what they're working on into the firm's R&D pipeline. The community brings together more than 250 employees across roles and experience levels to turn ideas into solutions at scale, quickly.

More news about: West Monroe

May 07, 2026, 10:47 ET SeaWorld Parks Unveil Coast-to-Coast Summer Spectacular Lineup in Orlando, San Diego and San Antonio

Summer Concert Series headlined by top artists from 90s and early‑2000s hip hop and R&B for an unforgettable musical journey featuring R&B, hip-hop and rap hits from the '90s and early 2000s.All-new summer offerings, beginning May 22, include:Ocean

More news about: SeaWorld

May 07, 2026, 10:47 ET 450 MHz LTE: silniejsza i inteligentniejsza sieć elektroenergetyczna dla Brazylii

BELO HORIZONTE (Brazylia)  , 7 maja 2026 r. /PRNewswire/ -- Każdego dnia miliony Brazylijczyków naciskają przycisk, włączają komputer, uruchamiają maszynę produkcyjną, a energia po prostu jest. To, co kryje się za tym przyciskiem,

More news about: Huawei

May 07, 2026, 10:18 ET Pylontech zaliczony do grona producentów rozwiązań do magazynowania energii o wysokich parametrach technicznych przez BloombergNEF

odporną i zrównoważoną przyszłość sektora energetycznego.PylontechZałożona w 2009 r. firma Pylontech (688063.SH) jest dostawcą systemów magazynowania energii na zamówienie, który od 2020 r. znajduje się w indeksie STAR Market, stając się pierwszym notowanym na giełdzie w Chinach przedsiębiorstwem,

More news about: Pylontech

May 07, 2026, 10:00 ET Housing affordability in California reaches a four-year high in first-quarter 2026, C.A.R. reports

r19r

More news about: CALIFORNIA ASSOCIATION OF REALTORS® (C.A.R.)

May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC

incurable, the Company's research and development ("R&D") costs were only $0.95 million and $1.07 million for the years ended June 30, 2025 and 2024, respectively.  This stands in stark contrast with Regencell's own representations that "[a]verage [R&D] to marketplace cost for a new medicine is nearly

More news about: Pomerantz LLP

May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW

Holdings, Inc. ("BRC"), formerly B. Riley Financial, Inc.  BRC's Co-Chief Operating Officer ("CEO") and Chairman of its Board of Directors is Bryant R. Riley ("Riley"). On November 4, 2025, B&W announced its entry into an agreement for a limited notice to proceed—that is, a preliminary agreement

More news about: Pomerantz LLP

May 07, 2026, 09:51 ET MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD

including those of cardiometabolic, oncology, gastroenterology, pneumology, and anti-inflammatory/analgesic products. Through its commitment in R&D and high quality manufacturing activities, Menarini continuously contributes to patients' health worldwide, maintaining the highest quality standards. 

More news about: Menarini Industrie Farmaceutiche Riunite

May 07, 2026, 09:26 ET ASUS to Showcase Next-Generation NVIDIA-Powered AI Infrastructure at AI+ Expo 2026

devices, components, and solutions to deliver incredible experiences that enhance the lives of people everywhere. With its team of 5,000 in-house R&D experts, ASUS is world-renowned for continuously reimagining today's technologies for tomorrow, garners more than 11 awards every day for quality,

More news about: ASUS Computer International

May 07, 2026, 09:18 ET TESSAN's Universal Travel Adapter Crowned "The Best Travel Adapter" in Esquire's 2026 Travel Awards

top-tier, robust industrial Research & Development, the TESSAN engineering team continues to shape the future of modern charging. Its multi-category R&D mastery was most recently evidenced by its design talent earning another coveted "Editor's Recommend" badge from the distinguished tech-authority Pocket-lint,

More news about: TESSAN

May 07, 2026, 09:15 ET Following Emotional Good Morning America Interviews, Kentucky Attorneys comment on the 15 Lawsuits filed to help UPS Plane Crash Victims Recover

Parcel Service Co. (Air), United Parcel Service Inc., Boeing Company, General Electric Company, VT San Antonio Aerospace Inc., the Estate of pilot Richard R. Wartenberg, and multiple Allianz insurance companies as defendants.Settlement Efforts Unsuccessful Despite Public StatementsThe

More news about: Peterson Law

May 07, 2026, 08:35 ET Allstacks Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Developer Productivity Insight Platforms

lives in the delivery pipeline. The third is engineering economics: connecting engineering execution to the financial outcomes it produces through R&D cost capitalization, investment allocation, and measurement of AI tool impact.Together, these pillars form an agentic system where always-on

More news about: Allstacks

May 07, 2026, 08:30 ET Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

million which represented a 7% increase compared to the same period in 2025.Research and Development (R&D) Expenses: R&D expenses for the first quarter of 2026 were $5.8 million, compared to $11.5 million in the same period in 2025. The reduction was driven

More news about: Theravance Biopharma, Inc.

May 07, 2026, 08:21 ET SANY Expands Global Intelligent Equipment Portfolio with Electric, Autonomous, and AI-Enabled Solutions

deployed, the unmanned paving-roller fleet has entered service, and the integrated smart solutions for ports and mines are now in operation. With annual R&D spending exceeding RMB 6 billion, SANY is accelerating its transformation from a traditional manufacturer into a robotics-focused, AI-enabled company.

More news about: SANY Group

May 07, 2026, 08:21 ET SANY Expands Global Intelligent Equipment Portfolio with Electric, Autonomous, and AI-Enabled Solutions

deployed, the unmanned paving-roller fleet has entered service, and the integrated smart solutions for ports and mines are now in operation. With annual R&D spending exceeding RMB 6 billion, SANY is accelerating its transformation from a traditional manufacturer into a robotics-focused, AI-enabled company.

More news about: SANY Group

May 07, 2026, 08:02 ET Ribo und Boehringer Ingelheim treiben ihr siRNA-Programm zur Behandlung der metabolischen Dysfunktion-assoziierten Steatohepatitis (MASH) weiter voran

Ingelheim wird dieses Programm weiter vorantreiben, mit dem Ziel, Menschen mit MASH neue Optionen zu bieten", sagte Li-Ming Gan, Co-CEO und Global R&D President von Ribo.siRNA-Therapeutika sind darauf ausgelegt, krankheitsverursachende Gene zu stilllegen, indem sie auf deren Boten-RNAs

More news about: Suzhou Ribo Life Science Co., Ltd.

May 07, 2026, 08:00 ET Pierre Fabre Pharmaceuticals Announces Regulatory Update Following Type A Meeting with U.S. Food and Drug Administration (FDA) on Tabelecleucel Biologic License Application (BLA)

living with this ultra-rare form of lymphoma urgently need an FDA-approved treatment option as none currently exist, and the lifespan of individuals with R/R EBV+ PTLD is often measured in weeks to months following failure of standard treatment."During the meeting, the FDA agreed that a single arm study

More news about: Pierre Fabre Pharmaceuticals